Drug Shortage Report for NAT-MONTELUKAST
Report ID | 226579 |
Drug Identification Number | 02522101 |
Brand name | NAT-MONTELUKAST |
Common or Proper name | Montelukast |
Company Name | NATCO PHARMA (CANADA) INC |
Market Status | MARKETED |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 4MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 30 UD BLS |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-04-29 |
Actual start date | 2024-04-30 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-01-02 |
Company comments | Long Term Back Order |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2025-01-02 | French | Compare |
v8 | 2025-01-02 | English | Compare |
v7 | 2024-12-16 | French | Compare |
v6 | 2024-12-16 | English | Compare |
v5 | 2024-07-05 | French | Compare |
v4 | 2024-07-05 | English | Compare |
v3 | 2024-04-30 | English | Compare |
v2 | 2024-04-29 | French | Compare |
v1 | 2024-04-29 | English | Compare |
Showing 1 to 9 of 9